Latest filing published 06 Apr 2023 for Stayble Therapeutics AB.
Insider track record
No signal scores available.
Mattias Münnich: trading record in brief
This profile gathers the share dealings of Mattias Münnich in Stayble Therapeutics AB. In total, 2 filings cover trades dated from 3 February 2021 to 5 April 2023.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 6 April 2023, reports a transaction in Stayble Therapeutics AB. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mattias Münnich
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 190,000 shares0Teckningsrätt/UniträttFI:csv-99f7d9681563d9a28410
- 190,000 shares0Teckningsrätt/UniträttFI:csv-12b20fc6be732908cdbb
2 of 2 declarations